Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study. (December 2016)

• Record Type: Journal Article
• Authors: Nakanishi, Rine; Ceponiene, Indre; Osawa, Kazuhiro; Luo, Yanting; Kanisawa, Mitsuru; Megowan, Nichelle; Nezarat, Negin; Rahmani, Sina; Broersen, Alexander; Kitslaar, Pieter H.; Dailing, Christopher; Budoff, Matthew J.
• Is Part Of: Atherosclerosis. Volume 255(2016)
• Page Start: 73
• Page End: 79
• Publication Date: 2016-12
• Subjects: Diabetes -- Plaque progression -- Coronary computed tomography angiography; Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2016.11.004
• Languages: English
• ISSNs: 0021-9150

Abstract

Abstract: Background and aims: We aimed at investigating whether diabetes is associated with progression in coronary plaque components. Methods: We identified 142 study subjects undergoing serial coronary computed tomography angiography. The resulting propensity score was applied 1:1 to match diabetic patients to non-diabetic patients for clinical risk factors, prior coronary stenting, coronary artery calcium (CAC) score and the serial scan interval, resulting in the 71 diabetes and 71 non-diabetes patients. Coronary plaque (total, calcified, non-calcified including fibrous, fibrous-fatty and low attenuation plaque [LAP]) volume normalized by total coronary artery length was measured using semi-automated plaque software and its change overtime between diabetic and non-diabetic patients was evaluated. Results: The matching was successful without significant differences between the two groups in all matched variables. The baseline volumes in each plaque also did not differ. During a mean scan interval of 3.4 ± 1.8 years, diabetic patients showed a 2-fold greater progression in normalized total plaque volume (TPV) than non-diabetes patients (52.8 mm 3 vs. 118.3 mm 3, p = 0.005). Multivariable linear regression model revealed that diabetes was associated with normalized TPV progression (β 72.3, 95%CI 24.3–120.3). A similar trend was observed for the non-calcified components, but not calcified plaque (β 3.8, 95%CI −27.0–34.7). Higher baseline CAC score was found to be associated with total, non-calcified and calcified plaque progression. However, baseline non-calcified volume but not CAC score was associated with LAP progression. Conclusions: The current study among matched patients indicates diabetes is associated with a greater plaque progression. Our results show the need for strict adherence of diabetic patients to the current preventive guidelines. Highlights: Plaque (total, non-calcified) volume change was higher in diabetes patients. There were no differences in calcified plaque progression. Baseline plaque volumes were associated with plaque progression.